Literature DB >> 26280273

Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.

Taisei Kobayashi1, Sahil A Parikh, Jay Giri.   

Abstract

Peripheral artery disease (PAD) is ubiquitous in the USA and is associated with a high burden of morbidity and mortality. Clinical manifestations of PAD are broad and range from the asymptomatic patient to intermittent claudication (IC) to critical limb ischemia (CLI). The efficacy of non-invasive treatment strategies for PAD has been well documented. These include smoking cessation, supervised exercise programs, and medical therapy. Strategies for invasive management of PAD are more controversial due to variability in the manifestations of PAD including lesion length, location, severity, and clinical presentation. This has made formal comparative effectiveness of interventional therapies in PAD challenging. The current review aims to summarize the most recent clinical research in the field of PAD in patients with IC, with a focus on the latest studies regarding risk factor modification and endovascular revascularization therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26280273     DOI: 10.1007/s11886-015-0643-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  65 in total

1.  SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use.

Authors:  Bruce H Gray; Larry J Diaz-Sandoval; Robert S Dieter; Michael R Jaff; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2014-07-18       Impact factor: 2.692

2.  Cigarette smoking and the outcome after lower limb arterial surgery.

Authors:  R Lassila; M Lepäntalo
Journal:  Acta Chir Scand       Date:  1988 Nov-Dec

3.  High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.

Authors:  Robert M Stoekenbroek; S Matthijs Boekholdt; Rana Fayyad; Rachel Laskey; Matti J Tikkanen; Terje R Pedersen; G Kees Hovingh
Journal:  Heart       Date:  2015-01-16       Impact factor: 5.994

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

6.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

7.  Angioplasty and provisional stent treatment of common femoral artery lesions.

Authors:  Robert F Bonvini; Aljoscha Rastan; Sebastian Sixt; Ulrich Beschorner; Elias Noory; Thomas Schwarz; Marco Roffi; Pierre-André Dorsaz; Uwe Schwarzwälder; Karlheinz Bürgelin; Roland Macharzina; Thomas Zeller
Journal:  J Vasc Interv Radiol       Date:  2013-01-28       Impact factor: 3.464

Review 8.  2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Vasc Surg       Date:  2011-09-29       Impact factor: 4.268

9.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

Review 10.  Exercise for intermittent claudication.

Authors:  Risha Lane; Brian Ellis; Lorna Watson; Gillian C Leng
Journal:  Cochrane Database Syst Rev       Date:  2014-07-18
View more
  1 in total

Review 1.  How To Assess a Claudication and When To Intervene.

Authors:  Prio Hossain; Damianos G Kokkinidis; Ehrin J Armstrong
Journal:  Curr Cardiol Rep       Date:  2019-11-14       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.